| A pan-cancer blueprint of the heterogeneous tumor microenvironment revealed by single-cell profiling J Qian, S Olbrecht, B Boeckx, H Vos, D Laoui, E Etlioglu, E Wauters, ... Cell research 30 (9), 745-762, 2020 | 576 | 2020 |
| Lineage-dependent gene expression programs influence the immune landscape of colorectal cancer HO Lee, Y Hong, HE Etlioglu, YB Cho, V Pomella, B Van den Bosch, ... Nature genetics 52 (6), 594-603, 2020 | 537 | 2020 |
| Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer I Joanito, P Wirapati, N Zhao, Z Nawaz, G Yeo, F Lee, CLP Eng, ... Nature genetics 54 (7), 963-975, 2022 | 212 | 2022 |
| Transition between fermentation and respiration determines history-dependent behavior in fluctuating carbon sources B Cerulus, A Jariani, G Perez-Samper, L Vermeersch, JMJ Pietsch, ... Elife 7, e39234, 2018 | 58 | 2018 |
| Recent advances in T-cell receptor repertoire analysis: bridging the gap with multimodal single-cell RNA sequencing S Valkiers, N de Vrij, S Gielis, S Verbandt, B Ogunjimi, K Laukens, ... ImmunoInformatics 5, 100009, 2022 | 51 | 2022 |
| The antifungal plant defensin HsAFP1 is a phosphatidic acid-interacting peptide inducing membrane permeabilization TL Cools, K Vriens, C Struyfs, S Verbandt, MHS Ramada, GD Brand, ... Frontiers in Microbiology 8, 2295, 2017 | 41 | 2017 |
| Single cell dynamics of tumor specificity vs bystander activity in CD8+ T cells define the diverse immune landscapes in colorectal cancer DM Borràs, S Verbandt, M Ausserhofer, G Sturm, J Lim, GA Verge, ... Cell Discovery 9 (1), 114, 2023 | 28 | 2023 |
| Microbiome confounders and quantitative profiling challenge predicted microbial targets in colorectal cancer development RY Tito, S Verbandt, M Aguirre Vazquez, L Lahti, C Verspecht, ... Nature medicine, 1-10, 2024 | 27 | 2024 |
| Pitfalls in machine learning‐based assessment of tumor‐infiltrating lymphocytes in breast cancer: A report of the International Immuno‐Oncology Biomarker Working Group on … J Thagaard, G Broeckx, DB Page, CA Jahangir, S Verbandt, Z Kos, ... The Journal of pathology 260 (5), 498-513, 2023 | 27 | 2023 |
| CD4+ T cell activation distinguishes response to anti-PD-L1+ anti-CTLA4 therapy from anti-PD-L1 monotherapy A Franken, M Bila, A Mechels, S Kint, J Van Dessel, V Pomella, ... Immunity 57 (3), 541-558. e7, 2024 | 24 | 2024 |
| Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno‐Oncology Biomarker Working Group on Breast … DB Page, G Broeckx, CA Jahangir, S Verbandt, RR Gupta, J Thagaard, ... The Journal of pathology 260 (5), 514-532, 2023 | 18 | 2023 |
| Yeast as a model for the identification of novel survival-promoting compounds applicable to treat degenerative diseases S Verbandt, BPA Cammue, K Thevissen Mechanisms of Ageing and Development 161, 306-316, 2017 | 16 | 2017 |
| IL-1R signaling drives enteric glia-macrophage interactions in colorectal cancer L van Baarle, V De Simone, L Schneider, S Santhosh, S Abdurahiman, ... Nature communications 15 (1), 6079, 2024 | 9 | 2024 |
| Colibactin-driven colon cancer requires adhesin-mediated epithelial binding M Jans, M Kolata, G Blancke, A D’Hondt, C Gräf, M Ciers, M Sze, A Thiran, ... Nature, 1-9, 2024 | 5 | 2024 |
| Image‐based multiplex immune profiling of cancer tissues: translational implications. A report of the International Immuno‐oncology Biomarker Working Group on Breast Cancer CA Jahangir, DB Page, G Broeckx, CA Gonzalez, C Burke, C Murphy, ... The Journal of pathology 262 (3), 271-288, 2024 | 5 | 2024 |
| Neoantigen identification: Technological advances and challenges T Pu, A Peddle, J Zhu, S Tejpar, S Verbandt Methods in Cell Biology 183, 265-302, 2024 | 2 | 2024 |
| A novel immune-based score and its immune contexture exploration in colorectal cancer. Q Wu, A Peddle, S Rusakiewicz, K Yin, Z Hu, F Van Herpe, A D'Hoore, ... Journal of Clinical Oncology 43 (4_suppl), 234-234, 2025 | | 2025 |
| Protein abundance of drug transporters and drug-metabolizing enzymes in paired healthy and tumor tissue from colorectal cancer patients S Steigert, J Brouwers, T Vanuytsel, S Verbandt, S Tejpar, S Oswald, ... International Journal of Pharmaceutics, 125216, 2025 | | 2025 |
| Unveiling the oncogenic role of LZTS1 in colorectal cancer Y Xu, D Pepe, S Yao, L Boudhan, S Verbandt, T Pu, JWM Creemers, ... Journal of Cellular and Molecular Medicine 28 (14), e18441, 2024 | | 2024 |
| Spatial analyses of immune cell infiltration in cancer: current methods and future directions. A report of the International Immuno‐Oncology Biomarker Working Group on Breast … D b Page, G Broeckx, C arif Jahangir, S Verbandt, R r Gupta, J Thagaard, ... The Journal of Pathology 260 (5), 514-532, 2023 | | 2023 |
